In an era where mental health is receiving rightful, increased attention, the global antidepressants market emerges as an arena of immense interest. With an annual growth observed in this space, the gravity of the subject resonates with projections of steady expansion over the next few years. The comprehensive market research report available sheds light on this dynamically evolving market, exploring its numerous dimensions.
The report dives into critical areas such as product sales, associated services, prevalent medications and their implications, while also shedding light on the diverse geographical market distribution. It delineates not only the striking trajectory of market growth during the pandemic but also addresses the challenges faced due to side effects of various antidepressant drugs. Strategically, the report charts key industry trends including the exploration of innovative treatments like Ketamine for resistant depression.
The extended purview allows readers to understand the outlook of the market in terms of changing dynamics, emerging sectors and the overall scope for growth. Embark on this journey into the future of the antidepressants market, to glean insights that could shape successful business strategies and forecast impending market changes.
The antidepressants market consists of sales of duloxetine, desvenlafaxine, vilazodone, citalopram, and sertraline. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent.
North America was the largest region in the antidepressants market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main product types of antidepressants are selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant (TCA), and monoamine oxidase inhibitor (MAOI). SSRIs (selective serotonin reuptake inhibitors) are a type of medication that is commonly used to treat depression and a few other mental illnesses. The various drug class includes monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants that are used for the treatment of the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder.
The antidepressants market has also surged during the COVID-19 outbreak. The increasing number of cases and fatalities is affecting mental health by elevating anxiety worldwide. People who are already living with mental health problems are experiencing increased stress levels over the COVID-19 outbreak. This has triggered the demand for antidepressant drugs.
Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder, and other mental diseases. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder. Globally, the percentage of people with depression varies from 2% to 6%, and the elderly are at greater risk of depression compared to other age groups. According to WHO, in 2020, about 264 million people of all ages worldwide suffered from depression. Therefore, rising cases of mental health disorders are expected to drive the growth of the antidepressant market.
The side effects of antidepressant drugs are a key factor hampering the growth of the antidepressant market. For instance, the antidepressants Lexapro (escitalopram) and Celexa (citalopram), both are used to treat depression and Lexapro also helps for treating anxiety. Lexapro and Celexa can cause side effects common to others which include nausea, sleeplessness, sweating, dry mouth, and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures, and vision issues. Therefore, the side effects of antidepressant drugs are expected to limit the growth of the antidepressant market.
The treatment of resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviors. For instance, Food and Drug Administration (FDA) approved a new ketamine depression drug esketamine which is one-half of the ketamine compound. The drug must be administered as a nasal spray and patients must be taking another antidepressant at the same time. Also, the drugs can be prescribed to only those patients who have (unsuccessfully) tried two antidepressants before.
In October 2021, Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, and other biotech products, announced that it has entered into a framework agreement to acquire a majority stake in Beijing Wonner Biotech Co., Ltd., for a deal amount of $30 million. Through this acquisition, Shineco aims to jointly develop SNG, a rapid-acting antidepressant natural innovative medicine. Beijing Winner is a biotechnology company based in China that specializes in the research and development of natural medicines and related products.
The countries covered in the antidepressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The antidepressants market research report is one of a series of new reports that provides antidepressants market statistics, including antidepressants industry global market size, regional shares, competitors with an antidepressants market share, detailed antidepressants market segments, market trends, and opportunities, and any further data you may need to thrive in the antidepressants industry. This antidepressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
Major players in the antidepressants market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd, Alkermes, Bristol Myers Squibb Company, Teva Pharmaceutical Industries, Eli Lilly and Co., Takeda Pharmaceutical Co. Ltd, Forest laboratories and Akeda Pharmaceutical.
This product will be delivered within 1-3 business days.
What is the estimated value of the Global Antidepressants Market?
What is the growth rate of the Global Antidepressants Market?
What is the forecasted size of the Global Antidepressants Market?
Who are the key companies in the Global Antidepressants Market?
|No. of Pages||175|
|Forecast Period||2022 - 2026|
| Estimated Market Value ( USD ||$ 16.44 billion|
| Forecasted Market Value ( USD ||$ 22.57 billion|
|Compound Annual Growth Rate||8.2%|
Table of Contents1. Executive Summary
2. Antidepressants Market Characteristics
3. Antidepressants Market Trends And Strategies
4. Antidepressants Market - Macro Economic Scenario
4.1 COVID-19 Impact On Antidepressants Market
4.2 Ukraine-Russia War Impact On Antidepressants Market
4.3 Impact Of High Inflation On Antidepressants Market
5. Antidepressants Market Size And Growth
5.1. Global Antidepressants Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Antidepressants Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Antidepressants Market Segmentation
6.1. Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
- Tricyclic Antidepressant (TCA)
- Monoamine Oxidase Inhibitor (MAOI)
- Monoamine oxidase inhibitors
- Serotonin antagonist and reuptake inhibitors
- Serotonin-norepinephrine reuptake inhibitors
- Selective serotonin reuptake inhibitors
- Tricyclic antidepressants 3
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
7.1. Global Antidepressants Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Antidepressants Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Antidepressants Market
8.1. Asia-Pacific Antidepressants Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
9. China Antidepressants Market
9.1. China Antidepressants Market Overview
9.2. China Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Antidepressants Market
10.1. India Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Antidepressants Market
11.1. Japan Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Antidepressants Market
12.1. Australia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Antidepressants Market
13.1. Indonesia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Antidepressants Market
14.1. South Korea Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Antidepressants Market
15.1. Western Europe Antidepressants Market Overview
15.2. Western Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Antidepressants Market
16.1. UK Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Antidepressants Market
17.1. Germany Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Antidepressants Market
18.1. France Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Antidepressants Market
19.1. Eastern Europe Antidepressants Market Overview
19.2. Eastern Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Antidepressants Market
20.1. Russia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Antidepressants Market
21.1. North America Antidepressants Market Overview
21.2. North America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Antidepressants Market
22.1. USA Antidepressants Market Overview
22.2. USA Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Antidepressants Market
23.1. South America Antidepressants Market Overview
23.2. South America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Antidepressants Market
24.1. Brazil Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Antidepressants Market
25.1. Middle East Antidepressants Market Overview
25.2. Middle East Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Antidepressants Market
26.1. Africa Antidepressants Market Overview
26.2. Africa Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Antidepressants Market Competitive Landscape And Company Profiles
27.1. Antidepressants Market Competitive Landscape
27.2. Antidepressants Market Company Profiles
27.2.1. Allergan PLC
22.214.171.124. Products and Services
126.96.36.199. Financial Performance
188.8.131.52. Products and Services
184.108.40.206. Financial Performance
27.2.3. Eli Lilly and Company
220.127.116.11. Products and Services
18.104.22.168. Financial Performance
27.2.4. GlaxoSmithKline PLC
22.214.171.124. Products and Services
126.96.36.199. Financial Performance
27.2.5. H. Lundbeck AS
188.8.131.52. Products and Services
184.108.40.206. Financial Performance
28. Antidepressants Pipeline Analysis
29. Key Mergers And Acquisitions In The Antidepressants Market
30. Antidepressants Market Future Outlook and Potential Analysis
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. About the Publisher
31.6. Copyright And Disclaimer
Executive SummaryAntidepressants Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antidepressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI); Serotonin-norepinephrine Reuptake Inhibitor (SNRI); Tricyclic Antidepressant (TCA); Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors; Serotonin Antagonist And Reuptake Inhibitors; Serotonin-Norepinephrine Reuptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder; Obsessive-Compulsive Disorder; Generalized Anxiety Disorder; Panic Disorder
Companies Mentioned: Allergan PLC; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline PLC; H. Lundbeck AS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
A selection of companies mentioned in this report includes:
- Allergan PLC
- Eli Lilly and Company
- GlaxoSmithKline PLC
- H. Lundbeck AS
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co. Inc.
- Sun Pharmaceuticals Pvt. Ltd.
- Bristol Myers Squibb Company
- Teva Pharmaceutical Industries
- Eli Lilly and Co.
- Takeda Pharmaceutical Co. Ltd.
- Forest laboratories
- Akeda Pharmaceutical